Apellis Pharmaceuticals (APLS) Q3 2025 Earnings

Jul 31Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.74
-0.59
-0.44
-0.29

Details

Expected EPS
-0.465485
Actual EPS
-0.33
Surprise EPS
0.14
Surprise Percent
+29.11%

Description

⁨Apellis Pharmaceuticals⁩ (⁦APLS⁩) has reported earnings of ⁦-0.33⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts